Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.2310
-0.0111 (-4.58%)
At close: Jun 8, 2026, 4:00 PM EDT
0.2350
+0.0040 (1.73%)
After-hours: Jun 8, 2026, 7:59 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Premium Nutritional Supplements | 21.80K | - | | - | - | - | |
Pharmaceutical Operations | - | - | | 233.28K | 638.04K | 1.13M | |
Pharmaceutical Operations Growth | - | - | | -63.44% | -43.35% | - | |
| 21.80K | - | | 233.28K | 638.04K | 1.13M | |
| - | - | | -63.44% | -43.35% | - | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 21.80K | - | | 233.28K | 638.04K | 1.13M | |
| - | - | | -63.44% | -43.35% | - | |
| 21.80K | - | | 233.28K | 638.04K | 1.13M | |
| - | - | | -63.44% | -43.35% | - | |
Source: S&P Global Market Intelligence.
